Tundra Space

Tundra Space

Book DemoDirectoryLog InSign Up

Clinical Research Directory

Browse clinical research sites, groups, and studies.

SitesGroupsStudies
Back to Studies
RECRUITING
NCT06381375

Drug-drug Interactions With Anti-tuberculous Drugs

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

This study aims to assess the prevalence and the outcome of prescribing drugs known to have major drug-drug interactions with anti-tuberculous drugs among Kasr Alainy tuberculous patients.

Official title: Assessment of the Prevalence and the Outcome of Prescribing Drugs Known to Have Major Drug-Drug Interactions With Anti-tuberculous Drugs Among Kasr Alainy Tuberculous Patients

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

400

Start Date

2024-04-30

Completion Date

2025-02-15

Last Updated

2024-08-22

Healthy Volunteers

No

Conditions

Drug-drug Interaction

Interventions

OTHER

Anti Tuberculosis Drug

1. Estimate the prevalence of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients. 2. Assess the outcome of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients (response to treatment and the prevalence of life-threatening events).

Locations (1)

Omnia Azmy Nabeh

Cairo, Egypt